Haig Barrett

Activities: Marketing

Trending Articles

  1. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  2. Moderna bags $590m US investment to accelerate mRNA-based bird flu vaccine development The pharmaceutical company's investigational influenza vaccine targets the H5 and H7 varieties, and is currently being prepared for Phase III trials
  3. Servier expands AI partnership with Google Cloud to bolster pharma R&D efforts The company will utilise AI and generative AI technology to optimise its therapeutic target/drug discovery and development processes
  4. Kindeva Drug Delivery to supply nerve agent antidote autoinjector to the US SNS The CDMO will produce the DuoDote autoinjecter containing atropine and pralidoxime chloride at its fill/finish manufacturing facility in St Louis, Missouri
  5. Navin Molecular constructs a new R&D facility in Dewas, India The laboratory will enhance the CDMO's small molecule laboratory- and kilo-scale process development capabilities, as well as its analytical development and testing capacity

Upcoming event

Pharma Packaging and Labelling Forum

5–6 March 2025 | Conference | San Diego, US See all

Related Content

Research & Development

Leaders of transformation

Haig Armaghanian, founder and CEO of Haig Barrett, explores how synthetic biology pioneers are revolutionising therapeutic development
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Getting drug pricing right

The pharmaceutical sector has faced growing criticism in recent years for the high price of its medicinal products. In the face of strong regulatory, sociopolitical and competitive market forces, getting pricing 'right' is challenging but essential for the success of the industry, companies, stockholders and patients
Subscribe now